Logo image of CYTK

CYTOKINETICS INC (CYTK) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:CYTK - US23282W6057 - Common Stock

64.13 USD
-1.54 (-2.35%)
Last: 12/8/2025, 4:30:02 PM
64.13 USD
0 (0%)
After Hours: 12/8/2025, 4:30:02 PM
Buy % Consensus

80

ChartMill assigns a Buy % Consensus number of 80% to CYTK. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 81.15. This target is 26.53% above the current price.
CYTK was analyzed by 26 analysts. The buy percentage consensus is at 80. So analysts seem to be have mildly positive about CYTK.
In the previous month the buy percentage consensus was at a similar level.
CYTK was analyzed by 26 analysts, which is quite many. So the average rating should be quite meaningful.
CYTK Historical Analyst RatingsCYTK Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -108 -98 -88 -78 -68 -58 -48 -38 -28 -18 -8 5 10 15 20 25

Price Target & Forecast

Price Low Median Mean High 64.1355.5580.5881.15126.00 - -13.38% 25.65% 26.53% 96.48%
CYTK Current Analyst RatingCYTK Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 5 10 15
Up and Down Grades
Date Firm Action Rating
2025-11-11 RBC Capital Maintains Outperform -> Outperform
2025-11-10 B. Riley Securities Reiterate Buy -> Buy
2025-10-06 Barclays Maintains Overweight -> Overweight
2025-10-02 B of A Securities Maintains Neutral -> Neutral
2025-09-29 HC Wainwright & Co. Reiterate Buy -> Buy
2025-09-22 B. Riley Securities Maintains Buy -> Buy
2025-09-22 HC Wainwright & Co. Reiterate Buy -> Buy
2025-09-03 Barclays Maintains Overweight -> Overweight
2025-09-03 Evercore ISI Group Maintains Outperform -> Outperform
2025-09-02 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-09-02 Needham Reiterate Buy -> Buy
2025-09-02 Stifel Maintains Buy -> Buy
2025-09-02 Citigroup Maintains Buy -> Buy
2025-08-08 Citigroup Maintains Buy -> Buy
2025-06-09 JP Morgan Maintains Overweight -> Overweight
2025-05-29 Mizuho Maintains Outperform -> Outperform
2025-05-14 Needham Reiterate Buy -> Buy
2025-05-08 Barclays Maintains Overweight -> Overweight
2025-05-07 RBC Capital Maintains Outperform -> Outperform
2025-05-07 Citigroup Maintains Buy -> Buy
2025-05-02 UBS Maintains Neutral -> Neutral
2025-05-02 Needham Reiterate Buy -> Buy
2025-04-24 Barclays Initiate Overweight
2025-04-21 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-15 B of A Securities Maintains Neutral -> Neutral
2025-04-15 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-10 JMP Securities Reiterate Market Outperform -> Market Outperform
2025-04-08 Needham Reiterate Buy -> Buy
2025-04-04 HC Wainwright & Co. Reiterate Buy -> Buy
2025-04-03 Citizens Capital Markets Reiterate Market Outperform -> Market Outperform

CYTOKINETICS INC / CYTK FAQ

What is the price target for CYTK stock?

26 analysts have analysed CYTK and the average price target is 81.15 USD. This implies a price increase of 26.53% is expected in the next year compared to the current price of 64.13.


What is the consensus rating for CYTOKINETICS INC (CYTK) stock?

The consensus rating for CYTOKINETICS INC (CYTK) is 80 / 100 . This indicates that analysts generally have a positive outlook on the stock.


How many analysts have analysed CYTOKINETICS INC (CYTK)?

The number of analysts covering CYTOKINETICS INC (CYTK) is 26.